Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age between 35-55 years Subjects with HbA1c greater than 6.5 percent Confirmed positive for Cardiovascular Autonomic Neuropathy (CAN) Duration of Type 2 Diabetes Mellitus (T2DM) between 1-10 years in the identified subjects Subjects with Pittsburgh Sleep Quality Index (PSQI) global score greater than 5 Patients using oral hypoglycemic agents only.
Exclusion criteria
Exclusion criteria: Patients with any severe cardiovascular disease. Patients with stage 2 hypertension Patients with any clinical orthopaedic problems that could limit his/her ability to participate in exercise training without inducing pain. Patients involved in any structured exercise training from last 6 months will be excluded. Patients who could not walk independently or have vision or hearing impairment will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate variability Heart rate recovery Glycemic controlTimepoint: baseline and after 6 weeks intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep quality Functional capacity Body composition Health related quality of life (HRQOL)Timepoint: baseline and after 6 weeks intervention | — |
Countries
India
Contacts
Jamia Millia Islamia